• Baseline circulating blood cell counts and ratios and changes therein for predicting immune-related adverse events during immune checkpoint inhibitor therapy: a multicenter, prospective, observational, pan-cancer cohort study with a gender perspective 

      Teijeira, Lucía; Martínez Kareaga, Mireia; Moreno, Amaia; Elejoste, Ibone de; Ibáñez Beroiz, B. Upna Orcid; Arrazubi, Virginia; Díaz de Corcuera, Isabela; Elejalde, Iñaki; Campillo-Calatayud, Ana; Les Bujanda, Íñigo (MDPI, 2024)   Artículo / Artikulua  OpenAccess
      Several factors have been associated with the occurrence of immune-related adverse events (irAEs) induced by immune checkpoint inhibitor (ICI) therapy. Despite their availability, the predictive value of circulating blood ...
    • Circulating low density neutrophils are associated with resistance to anti-PD1 immunotherapy in squamous head and neck cancer 

      Arrazubi, Virginia; Goñi Irigoyen, Saioa Upna Orcid; González Borja, Iranzu; Hernández García, Irene; Arasanz Esteban, Hugo; Pérez Sanz, Jairo; Bocanegra Gondán, Ana Isabel; Kochan, Grazyna; Escors Murugarren, David; Ruiz de Azúa, Yerani; Elizalde, Jesús María; Viúdez, Antonio; Vera García, Ruth (Wiley, 2023)   Artículo / Artikulua
      Background: Identification of predictive biomarkers to Immune checkpoint inhibitors (ICIs) in head and neck cancer (HNSCC) is an unmet need. Methods: This was a prospective observational study including 25 patients with ...
    • Cytokines and lymphoid populations as potential biomarkers in locally and borderline pancreatic adenocarcinoma 

      González Borja, Iranzu; Viúdez, Antonio; Alors-Pérez, Emilia; Goñi Irigoyen, Saioa Upna Orcid; Amat Villegas, Irene Upna; Ghanem, Ismael; Pazo-Cid, Roberto; Feliu, Jaime; Alonso, Laura; López López, Carlos; Arrazubi, Virginia; Gallego, Javier; Pérez Sanz, Jairo; Hernández García, Irene; Vera García, Ruth; Castaño, Justo P.; Fernández Irigoyen, Joaquín Upna Orcid (MDPI, 2022)   Artículo / Artikulua  OpenAccess
      Despite its relative low incidence, PDAC is one of the most aggressive and lethal types of cancer, being currently the seventh leading cause of cancer death worldwide, with a 5-year survival rate of 10.8%. Taking into ...
    • Deciphering CHFR role in pancreatic ductal adenocarcinoma 

      González Borja, Iranzu; Alors-Pérez, Emilia; Amat Villegas, Irene Upna; Alonso, Laura; Viyuela-García, Cristina; Goñi Irigoyen, Saioa Upna Orcid; Reyes, José C.; Ceballos-Chávez, María; Hernández García, Irene; Sánchez-Frías, Marina E.; Santamaría, Enrique; Razquin, Socorro; Arjona Sánchez, Álvaro; Arrazubi, Virginia; Pérez Sanz, Jairo; Vera García, Ruth; Fernández Irigoyen, Joaquín Upna Orcid; Castaño, Justo P.; Viúdez, Antonio (Frontiers Media, 2021)   Artículo / Artikulua  OpenAccess
      Checkpoint with forkhead-associated and ring finger domains (CHFR) has been proposed as a predictive and prognosis biomarker for different tumor types, but its role in pancreatic ductal adenocarcinoma (PDAC) remains unknown. ...
    • Tailored prevention of functional decline through a multicomponent exercise program in hospitalized oncogeriatric patients: study protocol for a randomized clinical trial 

      Martínez Velilla, Nicolás; Arrazubi, Virginia; Zambom Ferraresi, Fabíola Upna Orcid; Morilla Ruiz, Idoia; López Sáez de Asteasu, Mikel; Ramírez Vélez, Robinson; Zambom Ferraresi, Fabrício Upna Orcid; Casa Marín, Antón de la; Ollo Martínez, Iranzu; Gorospe-García, Itziar; Gurruchaga Sotés, Ibon; Galbete Jiménez, Arkaitz Upna Orcid; Cedeño Veloz, Bernardo Abel; Martín-Nevado, L.; Izquierdo Redín, Mikel; Vera García, Ruth (Elsevier, 2023)   Artículo / Artikulua  OpenAccess
      BACKGROUND: Cancer mostly affects older adults, causing a wide variety of diagnostic and therapeutic dilemmas. One of the most important moments in cancer patients is the hospitalization period, in which older patients ...

      El Repositorio ha recibido la ayuda de la Fundación Española para la Ciencia y la Tecnología para la realización de actividades en el ámbito del fomento de la investigación científica de excelencia, en la Línea 2. Repositorios institucionales (convocatoria 2020-2021).
      Logo MinisterioLogo Fecyt